Why Vertex's Dilemma Makes It the Best Biotech Stock to Buy Now
Excellent clinical trial results are giving Vertex a problem most biotechs wish they had.
Some fear the move could mean less work for models, photographers and make-up artists. from BBC News https://ift.tt/OyanBAr
0 comments:
Post a Comment